Search Results - "Smisek, Petr"
-
1
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia
Published in Haematologica (Roma) (01-01-2022)“…Antibodies against polyethylene glycol (PEG) in healthy subjects raise concerns about the efficacy of pegylated drugs. We evaluated the prevalence of…”
Get full text
Journal Article -
2
Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group
Published in Journal of clinical oncology (10-02-2013)“…In pediatric relapsed acute myeloid leukemia (AML), optimal reinduction therapy is unknown. Studies suggest that liposomal daunorubicin (DNX; DaunoXome; Galen,…”
Get full text
Journal Article -
3
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study
Published in Haematologica (Roma) (01-09-2019)“…Asparagine levels in cerebrospinal fluid and serum asparaginase activity were monitored in children with acute lymphoblastic leukemia treated with…”
Get full text
Journal Article -
4
Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS
Published in Haematologica (Roma) (01-03-2022)Get full text
Journal Article -
5
The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01
Published in Haematologica (Roma) (01-09-2014)“…The prognostic significance of early response to treatment has not been reported in relapsed pediatric acute myeloid leukemia. In order to identify an early…”
Get full text
Journal Article -
6
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study
Published in Journal of clinical oncology (10-03-2024)“…The AIEOP-BFM ALL 2009 protocol included, at the end of the induction phase, a randomized study of patients with high-risk (HR) ALL to investigate if an…”
Get full text
Journal Article -
7
A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS
Published in The Journal of experimental medicine (01-02-2021)“…The identification and characterization of rare immune cell populations in humans can be facilitated by their growth advantage in the context of specific…”
Get full text
Journal Article -
8
A homozygous deletion in the SLC19A1 gene as a cause of folate-dependent recurrent megaloblastic anemia
Published in Blood (25-06-2020)Get full text
Journal Article -
9
-
10
Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 Study
Published in Therapeutic drug monitoring (01-06-2020)“…Therapeutic drug monitoring (TDM) can identify patients with subtherapeutic asparaginase (ASNase) activity [silent inactivation (SI)] and prospectively guide…”
Get full text
Journal Article -
11
Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach
Published in European journal of drug metabolism and pharmacokinetics (01-03-2022)“…Background and Objectives Besides allergic reactions, antibodies against polyethylene glycol (PEG) have been associated with reduced PEG-asparaginase…”
Get full text
Journal Article -
12
Folate-Dependent Normocytic Anemia Caused By a Hypomorphic Mutation in SLC19A1 gene
Published in Blood (29-11-2018)“…Next generation sequencing has enabled rapid diagnosis of patients with monogenic diseases and discovery of novel disease-causing variants. However, the…”
Get full text
Journal Article -
13
Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data
Published in European journal of drug metabolism and pharmacokinetics (01-03-2021)“…Background and Objectives The pharmacokinetics of polyethylene glycol-conjugated asparaginase (PEG-ASNase) are characterized by an increase in elimination over…”
Get full text
Journal Article -
14
Therapeutic Drug Monitoring of Asparaginase Activity-Method Comparison of MAAT and AHA Test Used in the International AIEOP-BFM ALL 2009 Trial
Published in Therapeutic drug monitoring (01-02-2018)“…In the international AIEOP-BFM ALL 2009 trial, asparaginase (ASE) activity was monitored after each dose of pegylated Escherichia coli ASE (PEG-ASE). Two…”
Get full text
Journal Article -
15
The Prognostic Impact of Cytogenetics and Karyotype Changes in Pediatric Patients with Relapsed Acute Myeloid Leukemia: A Retrospective Cohort Study within the Relapsed AML 2001/01 Study
Published in Blood (02-12-2016)“…Introduction After treatment response, cytogenetics and molecular aberrations are the most important prognostic factors in children with de novo acute myeloid…”
Get full text
Journal Article Conference Proceeding -
16
Fanconi anemia with biallelic FANCD1 / BRCA2 mutations – Case report of a family with three affected children
Published in European journal of medical genetics (01-03-2016)“…Abstract Fanconi anemia, complementation group D1 with bi-allelic FANCD1 ( BRCA2) mutations, is a very rare genetic disorder characterized by early onset of…”
Get full text
Journal Article -
17
Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia
Published in Haematologica (Roma) (01-12-2013)“…Clinical and genetic heterogeneity renders confirmation or exclusion of autoimmune lymphoproliferative syndrome difficult. To re-evaluate and improve the…”
Get full text
Journal Article -
18
Jumping translocations in bone marrow cells of pediatric patients with hematologic malignancies: a rare cytogenetic phenomenon
Published in Cancer genetics (01-06-2011)Get full text
Journal Article -
19
B Precursor ALL Subset with Aberrant CD2 Expression and a Specific Predisposition to Early Monocytic Transdifferentiation
Published in Blood (19-11-2010)“…Abstract 1708 Anecdotic observations of B precursor (BCP) ALL patients with aberrant CD2 expression at diagnosis and a significant shift of phenotype towards…”
Get full text
Journal Article -
20
Central Nervous System (CNS) Involvement In Pediatric Relapsed Acute Myeloid Leukemia: Results and Lessons From Study Relapsed AML 2001/01
Published in Blood (19-11-2010)“…Abstract 184 Acute Myeloid Leukemia - Therapy, excluding Transplantation: Pediatric and Adult AML Therapy With improving initial antileukemic therapy, CNS…”
Get full text
Journal Article